These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17786072)

  • 1. Renin inhibitors in the management of hypertension.
    Oparil S
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):706-7. PubMed ID: 17786072
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin inhibition: the holy grail of renin-angiotensin system blockade?
    McInnes GT
    J Hum Hypertens; 2007 Oct; 21(10):766-9. PubMed ID: 17541389
    [No Abstract]   [Full Text] [Related]  

  • 3. Complete renin-angiotensin-aldosterone system (RAAS) blockade in high-risk patients: recent insights from renin blockade studies.
    Rajagopalan S; Bakris GL; Abraham WT; Pitt B; Brook RD
    Hypertension; 2013 Sep; 62(3):444-9. PubMed ID: 23876474
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolution of renin-angiotensin blockade: angiotensin-converting enzyme inhibitors as the starting point.
    Sica DA
    Curr Hypertens Rep; 2010 Apr; 12(2):67-73. PubMed ID: 20424943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renin as a target of direct pharmacological block in arterial hypertension].
    Mukhin NA; Fomin VV
    Ter Arkh; 2009; 81(8):5-9. PubMed ID: 19799192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct renin inhibition--commonly asked questions.
    Sica DA
    J Clin Hypertens (Greenwich); 2008 Nov; 10(11):871-5. PubMed ID: 19128278
    [No Abstract]   [Full Text] [Related]  

  • 7. Optimal renin-angiotensin system blockade-wishful thinking?
    Makani H; Bangalore S; Messerli FH
    Nat Rev Cardiol; 2013 Aug; 10(8):486. PubMed ID: 23817190
    [No Abstract]   [Full Text] [Related]  

  • 8. [Renin inhibition in hypertension].
    Güleç S
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():15-22. PubMed ID: 20019472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply: Optimal renin-angiotensin-aldosterone system blockade--wish fulfilled.
    Nussberger J; Bohlender J
    Nat Rev Cardiol; 2013 Aug; 10(8):486. PubMed ID: 23817186
    [No Abstract]   [Full Text] [Related]  

  • 10. The development of the direct renin inhibitor aliskiren: treating hypertension and beyond.
    Siragy H; Huang J; Lieb DC
    Expert Opin Emerg Drugs; 2008 Sep; 13(3):417-30. PubMed ID: 18764720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct renin inhibitors in hypertension - approaching the moment of truth.
    Hedner T; Narkiewicz K; Oparil S; Kjeldsen SE
    Blood Press; 2012 Oct; 21(5):267-8. PubMed ID: 23013445
    [No Abstract]   [Full Text] [Related]  

  • 12. Renin inhibition--benefit beyond hypertension control.
    Kher V
    J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapy: Optimal blockade of the renin-angiotensin-aldosterone system.
    Nussberger J; Bohlender J
    Nat Rev Cardiol; 2013 Apr; 10(4):183-4. PubMed ID: 23478259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aliskiren, the future of renin-angiotensin system blockade?
    Uresin Y; Mehtar Bozkurt M; Sabirli S; Ozunal ZG
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):835-49. PubMed ID: 17867914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blockers of renin-angiotensin-aldosterone system in the treatment of arterial hypertension: classics versus the modern].
    Kanorskiĭ SG
    Kardiologiia; 2013; 53(10):89-95. PubMed ID: 24645559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct renin inhibition: another weapon to modulate the renin-angiotensin system in postinfarction remodeling?
    Perlini S; Salinaro F; Fonte ML
    Hypertension; 2008 Dec; 52(6):1019-21. PubMed ID: 18955659
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of inhibitors of the aspartyl protease renin for the treatment of hypertension.
    Scott BB; McGeehan GM; Harrison RK
    Curr Protein Pept Sci; 2006 Jun; 7(3):241-54. PubMed ID: 16787263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blockade of renin-angiotensin-aldosterone system in hemodialysis patients to control hypertension and prevent cardiovascular disease: optimal pharmacotherapy.
    Morishita Y; Kusano E
    Cardiovasc Hematol Agents Med Chem; 2011 Oct; 9(4):241-6. PubMed ID: 22023537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel drugs targeting hypertension: renin inhibitors and beyond.
    Leibovitz E; Schiffrin EL
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):3-8. PubMed ID: 17666909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren: a new drug for an old problem.
    Barrios V; Escobar C
    Cardiovasc Hematol Agents Med Chem; 2010 Jan; 8(1):1-10. PubMed ID: 20210772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.